CV NASDAQ
CapsoVision, Inc.
1W: -7.3%
1M: +13.6%
3M: +44.7%
YTD: -33.9%
$6.64
-0.13 (-1.92%)
Weekly Expected Move ±11.3%
$5
$6
$6
$7
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$331.8M
52W Range3.434-15.37
Volume88,906
Avg Volume291,650
Beta-2.62
Dividend—
Analyst Ratings
Company Info
CEOKang-Huai Wang
Employees90
SectorHealthcare
IndustryMedical - Equipment & Services
IPO Date2001-09-03
Websitecapsovision.com/
Cox Avenue
Saratoga, CA 95070
US
Saratoga, CA 95070
US
14086241488
About CapsoVision, Inc.
Medicalâtechnology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics
Latest News
12 Health Care Stocks Moving In Monday's After-Market Session
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
Benchmark updates its best ideas list
CapsoVision targets 510(k) submission for Gen 2 Colon capsule and AI module in Q3 2026 as commercial adoption accelerates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Atkinson Douglas Pat | M-Exempt | 34,786 | $0.57 | 2026-05-05 |
| Atkinson Douglas Pat | M-Exempt | 34,786 | $0.57 | 2026-05-05 |
| Atkinson Douglas Pat | M-Exempt | 6,505 | $0.57 | 2026-05-04 |
| Atkinson Douglas Pat | M-Exempt | 30,030 | $0.37 | 2026-05-04 |
| Atkinson Douglas Pat | M-Exempt | 6,505 | $0.57 | 2026-05-04 |